Zobrazeno 1 - 10
of 143
pro vyhledávání: '"A. G. Bochkova"'
Autor:
I. Z. Gaidukova, A. I. Akulova, A. P. Rebrov, A. G. Bochkova, S. Ya. Startsev, Sh. Erdes, E. K. Gaidukova, D. A. Poddubny
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 1, Pp 56-61 (2019)
ASAS health index (ASAS HI) is a comprehensive tool developed on the basis of the international system of ICF (the International Classification of Functioning, Disability and Health) to quantify the health of patients with spondyloarthritis (SPA), in
Externí odkaz:
https://doaj.org/article/e40340de3eb04725bb6701c8c1beebef
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 2, Pp 189-195 (2018)
Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with
Externí odkaz:
https://doaj.org/article/882be11db9864651a3a63b95b69ae75c
Autor:
A. A. Godzenko, O. A. Rumyantseva, A. G. Bochkova, Yu. O. Korsakova, Sh. Erdes, V. V. Badokin
Publikováno v:
Современная ревматология, Vol 12, Iss 1, Pp 13-19 (2018)
Extraskeletal manifestations (ESMs) are commonly observed in ankylosing spondylitis (AS). The available data on the association of ESMs with the inflammatory activity and other clinical parameters of AS are contradictory.Objective: to assess the asso
Externí odkaz:
https://doaj.org/article/caef4d10230143d9a5f67e68c022acfd
Autor:
I. Z. Gaidukova, A. P. Rebrov, T. V. Korotaeva, T. V. Dubinina, E. N. Otteva, V. V. Badokin, A. G. Bochkova, O. V. Bugrova, A. A. Godzenko, A. I. Dubikov, O. N. Ivanova, S. A. Lapshina, O. B. Nesmeyanova, I. P. Nikishina, T. A. Raskina, O. A. Rumyantseva, A. V. Smirnov, A. V. Sitalo, Sh. F. Erdes
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 1, Pp 10-14 (2018)
The paper gives the definition of remission in axial spondyloarthritides (axSpA), which has been developed by the Spondyloarthritis Study Group of Experts. The work used the Delphi technique. At stage 1, based on the analysis of the data available in
Externí odkaz:
https://doaj.org/article/6c1203c5343345de8d14b88ad81d1b79
Autor:
I. Z. Gaidukova, A. P. Rebrov, S. A. Lapshina, E. N. Otteva, T. V. Dubinina, V. V. Badokin, A. G. Bochkova, O. V. Bugrova, A. A. Godzenko, A. I. Dubikov, O. N. Ivanova, T. V. Korotaeva, O. B. Nesmeyanova, I. P. Nikishina, T. A. Raskina, O. A. Rumyantseva, A. V. Smirnov, A. V. Sitalo, Sh. F. Erdes
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 5, Pp 474-484 (2017)
The paper gives recommendations for the drug therapy of axial spondyloarthritides, which have been developed by the Spondyloarthritis Study Group of Experts. The recommendations describe the patient management tactic in the most common clinical situa
Externí odkaz:
https://doaj.org/article/8d2837f304014386bee4d1b0936e3d8b
Autor:
A. A. Godzenko, Yu. O. Korsakova, O. A. Rumyantseva, A. G. Bochkova, V. V. Badokin, Sh. F. Erdes
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 5, Pp 509-513 (2017)
Involvement of the aorta and heart valves in ankylosing spondylitis (AS) is a manifestation of the systemic inflammatory process. Data on the frequency, clinical significance, and evolution of these manifestations are controversial.Objective: to esti
Externí odkaz:
https://doaj.org/article/e8a01e28b02149e7a940739d240f02b9
Autor:
T. V. Dubinina, I. Z. Gaidukova, A. A. Godzenko, S. A. Lapshina, A. P. Rebrov, O. A. Rumyantseva, V. V. Badokin, A. G. Bochkova, O. V. Bugrova, A. I. Dubikov, O. N. Ivanova, T. V. Korotaeva, O. B. Nesmeyanova, I. P. Nikishina, E. N. Otteva, T. A. Raskina, A. V. Smirnov, A. V. Sitalo, Sh. F. Erdes
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 4, Pp 344-350 (2017)
The paper gives the recommendations for the assessment of disease activity and functional status in patients with ankylosing spondylitis in clinical practice, which have been developed by experts, by taking into account international and Russian expe
Externí odkaz:
https://doaj.org/article/ebd614a6e0dd484d9ed690ca44f8f510
Autor:
A. A. Godzenko, A. G. Bochkova, O. A. Rumyantseva, Yu. O. Korsakova, I. Yu. Razumova, V. V. Badokin, Sh. F. Erdes
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 2, Pp 169-176 (2017)
Ankylosing spondylitis (AS) is a systemic inflammatory disease involving not only the skeleton, but also other organs. The data on the frequency and clinical significance of extraskeletal manifestations are contradictory. Objective: to assess the fre
Externí odkaz:
https://doaj.org/article/d0ddc342ddd2457db5cf5d70866113fd
INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS
Autor:
O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, M. V. Cherkasova, E. N. Aleksandrova, S. K. Solovyev, Sh. F. Erdes
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 1S, Pp 43-48 (2016)
At present, there are a number of unsolved problems associated with unawareness of the causes and ways to prevent the inefficacy of tumor necrosis factor-α inhibitors.Objective: to study the causes of secondary inefficacy of infliximab (INF), by ana
Externí odkaz:
https://doaj.org/article/014bc5f331234590aeccb53558bd3432
Autor:
A. A. Godzenko, A. G. Bochkova, O. A. Rumyantseva, I. Yu. Razumova, V. V. Badokin, Sh. F. Erdes
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 1S, Pp 33-37 (2016)
Relapsing uveitis is a serious problem for patients with ankylosing spondylitis (AS). Tumor necrosis factor-α inhibitors significantly reduce the frequency of uveitis attacks in AS patients, but they are not always available. In this connection, it
Externí odkaz:
https://doaj.org/article/20a42d8076e44d2282e4550c857ab51e